青藤碱在器官移植免疫耐受方面的研究进展

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:liang630223
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
器官移植术是当前公认的治疗各种终末期器官衰竭的有效学科甚至是常规手段。半个多世纪以来器官移植的手术技术已经非常成熟,目前影响器官移植患者术后生存率及生活质量的主要因素是器官间的免疫排斥反应。随着技术的进步,越来越多的新药物应用于抗免疫排斥反应。其中中药提取物具备有效且毒性低的优点,受到广泛关注。青藤碱是从中药青风藤中提纯出来的一种生物碱单体,其具有免疫抑制、抗炎、镇痛等作用,当前在器官抗免疫排斥反应的基础研究越来越广泛,是一种有良好应用前景的新型免疫抑制剂。 Organ transplantation is currently recognized as an effective and even routine means of treating various end-stage organ failure. For more than half a century, the surgical technique of organ transplantation has been very mature. The main factor that affects the postoperative survival rate and quality of life of organ transplant patients at present is the immune rejection between organs. As technology advances, more and more new drugs are used in anti-immune rejection. Among them, the traditional Chinese medicine extract has the advantages of being effective and low in toxicity, and attracts wide attention. Sinomenine is a kind of alkaloid monomer purified from traditional Chinese medicine Qingfengtan. It has immunosuppressive, anti-inflammatory and analgesic effects. At present, the basic research on organ rejection is more and more widespread New immunosuppressive agents with good application prospects.
其他文献
目的通过建立热毒所致的兔动脉粥样硬化(Atherosclerosis,AS)模型,研究黄连解毒汤(Huanglian Jiedu Decoction,HJD)对兔动脉粥样硬化及内皮祖细胞(Endothelial progenitor ce